BPC-157 does not have a single defined receptor rather, it modulates multiple convergent pathways: VEGF-VEGFR2-eNOS (angiogenesis and NO production), FAK-paxillin-actin (cytoskeletal remodelling and cell migration), NF-B suppression (anti-inflammatory), PI3K-Akt-Bcl-2 (anti-apoptotic), and EGR1-driven collagen/fibronectin gene transcription
You are an active person
Systemic effects that have been reported in trials, or that are mechanistically expected from elevated GH and IGF-1, include: Water retention and mild edema , particularly in the hands, ankles, and face Tingling, numbness, or 'pins and needles' (paresthesia) , sometimes linked to fluid pressure on nerves Headache and facial flushing , often shortly after administration Joint aches or stiffness (arthralgia) Transient changes in blood glucose due to GH's counter-regulatory effect on insulin Fatigue, dizziness, or a feeling of light-headedness in some individuals It is important to be candid about the limits of this evidence
The clinical trial found statistically significant reductions in both muscle soreness and inflammatory markers
Some, like genetics and age, are beyond your control
Ozempic ( Semaglutide GLP-1 ) impacts metabolism by mimicking the natural hormone GLP-1 (glucagon-like peptide-1), which plays an essential role in regulating how your body processes food and energy
